Advertisement

Other Modalities of Treatment

  • Vibhakar Vachhrajani
  • Payal Khakhkhar
Chapter
  • 450 Downloads

Abstract

  1. (a)

    Local oxygen therapy:

    Molecular oxygen is essential during the process of inflammation and repair. Local oxygen therapy increases growth factor expression, increases angiogenesis. Local oxygen therapy is not HBOT. Air tight bag and oxygen are the only requirements. It is also available in portable model and in-hospital delivery device. More clinical trials require to prove its efficacy.

     
  2. (b)

    Ozone therapy:

    Ozone is a colorless, pungent odor gas. It is an oxidizing agent and is used in medical condition since nineteenth century. It has disinfecting, oxidizing, and deodorizing properties. It also can decolorize. It is used locally with an airtight bag for wound healing. It is used in diabetic foot wounds, ischemic wounds and necrotizing fasciitis. For other conditions it is administered per rectally and intravenously.

     
  3. (c)

    Hyper baric oxygen therapy:

    2–2.5 ATA (atmosphere absolute) pressure is used in hyper baric oxygen therapy.

    This therapy results in arterial oxygen tension to around 2000 mmHg and that in tissues of around 400 mmHg. The therapy is given for 90–120 min per day. It is much better than local oxygen therapy. It is best used for post revascularization residual ischemia and PVD with non-operable disease.

     
  4. (d)

    NPWT:

    For removal of exudates, to reduce toxic material and bacterial load, to increase neovascularization and to reduce wound edema, NPWT is an excellent therapy. −125 to −75 mmHg pressure is used in NPWT.A specialized type of foam or sponge is used. Drug delivery and oxygen delivery devices are available in new generation NPWT devices. It is contraindicated in malignancy, fistula, and over exposed blood vessels and nerves.

     
  5. (e)

    Electric therapy & Ultrasonic therapy for wound debridement and healing:

    Though less utilized, electric therapy is useful for chronic wounds. Normal human skin is found to produce steady electrical potential. On injury to skin endogenous electrical current is produced. Electric therapy decreases bacterial infection, increases local perfusion, accelerates wound healing. It is not a form of radiation or heating, but it uses an electromagnetic field with the aim of stimulating healing.

    Ultrasound remains a controversial modality in wound management. Electrical waves are converted in to sound waves. Ultrasound is used for debridement. The process is known as cavitation. Vapor bubbles are formed near the surface and bubbles then collapse and disrupt the necrotic tissue. Ultrasound also has vasodilation effect which assists in healing. Low –frequency non-contact airborne ultrasound therapy is thought to be very effective in neuropathic diabetic foot ulcers.

     
  6. (f)

    Extracorporeal shock wave therapy:

    Extracorporeal shockwave therapy is very well known for urinary stone disease, but a few wound management surgeons use this therapy for wound healing also. Its role is for granulation tissue formation, re-epithelialization and vascular perfusion. There is recruitment of mesenchymal stem cells, anti-inflammatory as well as antimicrobial effect. The therapy is given once or twice weekly. 100–1000 shocks are given at 0.1 mj/mm2.

     
  7. (g)

    Compression therapy and devices.

    Wounds of the extremity heal better if there is no edema or swelling. Elevation of the limb, pressure bandage helps wounds to heal. Two layer and four layer compression bandages, inelastic bandages, elastic stockings and pneumatic compression devices are useful for healing process. These are especially useful in venous stasis ulcers.

     
  8. (h)

    Low level laser therapy:

    Carbon dioxide laser is used as a debriding device for diabetic foot wounds. Low level laser therapy is used for wound healing where it stimulates metabolic process, activates macrophages and increases microcirculation.

     

References

  1. 1.
    Allen DB, Maguire JJ, Mahdavian M, et al. Wound hypoxia and acidosis limit neutrophil bacterial killing mechanisms. Arch Surg. 1997;132:991–6.PubMedCrossRefGoogle Scholar
  2. 2.
    Jonsson K, Jenson JA, Goodsen WH, et al. Tissue oxygenation, anemia and perfusion in relation to wound healing in surgical patients. Ann Surg. 1991;214(5):605–13.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Sayadi LR, Banyard DA, Ziegler ME, Obagi Z, Prussak J, Klopfer MJ, Evans GRD, Widgerow AD. Topical oxygen therapy & micro/nanobubbles: a new modality for tissue oxygen delivery. Int Wound J. 2018;15(3):363–74.PubMedCrossRefGoogle Scholar
  4. 4.
    Moen n, Ugland H, Strömberg N, Sjöström E, Karlson A, Ringstad L, Bysell H, Amiry-Moghaddam M, Haglerød C. Development of a novel in situ gelling skin dressing: Delivering high levels of dissolved oxygen at pH 5.5. Health Sci Rep. 2018;1(7):e57.PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Copeland K, Purvis AR. A retrospective chart review of chronic wound patients treated with topical oxygen therapy. Adv Wound Care. 2017;6(5):143.CrossRefGoogle Scholar
  6. 6.
    Bocci VA. Scientific and medical aspects of ozone therapy. State of the art. Arch Med Res. 2006;37:425–35.PubMedCrossRefGoogle Scholar
  7. 7.
    Martinez-Sanchez G, Al-Dalain SM, Menendez S, Re L, Giuliani A, Candelario-Jalil E, Alvarez H, Fernandez M. Therapeutic efficacy of ozone in patients with diabetic foot. Eur J Pharmacol. 2005;523:151–61.PubMedCrossRefGoogle Scholar
  8. 8.
    Elvis AM, Ekta JS. Ozone therapy: a clinical review. J Nat Sci Biol Med. 2011;2(1):66–70.  https://doi.org/10.4103/09769668.82319.. PMC 3312702. PMID 22470237CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Wainstein J, Feldbrin Z, Boaz M, Harman-Boehm I. Efficacy of ozone-oxygen therapy for the treatment of diabetic foot ulcers. Diabetes Technol Ther. 2011;13:1255–60.PubMedCrossRefGoogle Scholar
  10. 10.
    Foreman C: The FDA and HBO. Presented at Hyperbaric Medicine 1998 Advanced Symposium, University of South Carolina School of Medicine, 1998.Google Scholar
  11. 11.
    Wang C, Schwaitzberg S, Berliner E, Zarin DA, Lau J. Hyperbaric oxygen for treating wound: a systematic review of the literature. Arch Surg. 2003;138:272–9.. discussion 280PubMedCrossRefGoogle Scholar
  12. 12.
    Feldmeier JJ, Hopf HW, Warriner RA, et al. UHMS position statement: Topical oxygen for chronic wounds. Undersea Hyperb Med. 2005;32(3):157–68.PubMedGoogle Scholar
  13. 13.
    Davis JC. Refractory osteomyelitis. In: Davis JC, Hunt TK, editors. Problem wounds: the role of oxygen. New York: Elsevier; 1988. p. 125–42.Google Scholar
  14. 14.
    Boerema I, Meyne NG, Brummelkamp WH, et al. Life without bllod. Ned Tijdschr Geneeskd. 1960;104:949–54.PubMedGoogle Scholar
  15. 15.
    Brummelkamp WH. Consideration on hyperbaric oxygen therapy at three atmosphere absolute for clostridial infection type welchii. Ann N Y Acad Sci. 1965;117:688–99.PubMedCrossRefGoogle Scholar
  16. 16.
    Thom SR, Taber RL, Mendiguren II, et al. Delayed neuropsychologic sequlae after carbon monoxide poisoning: Prevention by treatment with hyberbaric oxygen. Ann Emerg Med. 1995;25(4):474–80.PubMedCrossRefGoogle Scholar
  17. 17.
    Tarborough OD, Behnke AR. The treatment of compressed air illness utilizing oxygen. J Ind Hyg Toxicol. 1939;21(6):213–8.Google Scholar
  18. 18.
    Hart GB, Lamb RC, Strauss MB. Gas gangrene. J Trauma. 1983;23(11):991–1000.PubMedCrossRefGoogle Scholar
  19. 19.
    Bouachour G, Cronier P, Gouello JP, et al. Hyperbaric oxygen therapy in the management of crush injuries: A randomized double blind placebo controlled clinical trial. J Trauma. 1996;41(2):333–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Strauss MB, Hart GB. Crush injury and the role of hyperbaric oxygen. Top Emerg Med. 1984;6:9–24.Google Scholar
  21. 21.
    Tan CM, Im MJ, Myers RA, Hoopes JE. Effects of hyperbaric oxygen and hyperbaric air on the survival of island skin flaps. Plast Reconstr Surg. 1984;73(1):27–30.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Hunt TK, NIinikoski J, Zederfeldt BH, Silver IA. Oxygen in wound healing enhancement: cellular effects of oxygen. In: Davis JC, Hunt TK, editors. Hyperbaric oxygen therapy. Bethesda, MD: Undersea Medical Society; 1988. p. 111–22.Google Scholar
  23. 23.
    Baffer DJ. Pure and mixed aerobic and anaerobic soft tissue infections. Hypereb Oxygen Rev. 1985;6:65–96.Google Scholar
  24. 24.
    Gozal D, Ziser A, Shupak A, et al. Necrotising fasciitis. Arch Surg. 1986;121(2):233–5.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Riseman JA, ZAmboni WA, Curtis A, et al. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery. 1990;108(5):847–50.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Davis JC. Hyperbaric oxygen therapy. Intensive Care Med. 1989;4:555–7.Google Scholar
  27. 27.
    Davis JC. Chronic non hematogenous osteomyelitis treated with adjuvant hyperbaric oxygen. J Bone Joint Surg. 1996;68:A1210–7.CrossRefGoogle Scholar
  28. 28.
    Mader JT, Brown GL, Guckian JC, et al. A mechanism for the amelioration by hyperbaric oxygen of experimental staphylococcal osteomyelitis in rabbits. J Infect Dis. 1980;142(6):915–22.PubMedCrossRefGoogle Scholar
  29. 29.
    Morrey BF, Dunn JM, Heimbach RD, Davis J. Hyperbaric oxygen and chronic osteomyelitis. Clin Orthop Relat Res. 1979;144:121–7.Google Scholar
  30. 30.
    Slack WK, Thomas DA, Perrins D. Hyperbaric oxygenation chronic osteomyelitis. Lancet. 1965;14:1093–4.CrossRefGoogle Scholar
  31. 31.
    Feldmeier JJ, Heimbach DA, Davolt DA, Brakora MJ. Hyperbaric oxygen as an adjunctive treatment for severe laryngeal necrosis: A report og nine consecutive cases. Undersea Hyperb Med. 1993;20(4):329–35.PubMedGoogle Scholar
  32. 32.
    Feldmeier JJ, Heimbach RD, Davolt DA, et al. Hyperbaric oxygen as an adjunctive treatment for delayed radiation injury ofnthe chest wall: A retrospective review of twenty- three cases. Undersea Hyperb Med. 1995;22(4):383–93.PubMedGoogle Scholar
  33. 33.
    Kaelin CM, Im MJ, Myres RA, et al. The effects of hyperbaric oxygen on free flaps in rats. Arch Surg. 1990;125(5):607–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Zamboni WA, Roth AC, Russell RC, et al. The effect of acute hyperbaric oxygen therapy on axial pattern skin flap survival when administered during and after total ischemia. J Reconstr Microsurg. 1989;5(4):343–7.; discussion 349-350.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Zatz R, Brenner BM. Pathogenesis of Diabetic microangiography: The hemodynamic view. Am J Med. 1986;80(3):443–53.PubMedCrossRefGoogle Scholar
  36. 36.
    Doctor N, Pandya S, Supe A. Hyperbaric oxygen therapy in diabetic foot. J Postgrad Med. 1992;38(3):112–4.PubMedGoogle Scholar
  37. 37.
    Wood JD. GABA and oxygen toxicity: a review. Brain Res Bull. 1980;6:777–80.CrossRefGoogle Scholar
  38. 38.
    Wood JD, Peesker SJ, Rozdilsky B. SEnsityvity of GABA sunthesis in human brain to oxygen poisoning. Aviat Space Environ Med. 1975;146(9):1155–6.Google Scholar
  39. 39.
    Yoneda Y, Kuriyama K, Takahashi M. Modulation of synaptic GABA receptor binding by membrane phospholipids: Possible role of active oxygen radicals. Brain Res. 1985;333(1):111–22.. (levin’s page no 362)PubMedCrossRefGoogle Scholar
  40. 40.
    Clark J. Side effects and complications. Kensington, MD: Undersea and Hyperbaric Medical Society; 2003.. levin’s page no 362Google Scholar
  41. 41.
    Armstrong DG, Attinger CE, Boulton AJM, et al. Guidelines regarding negative pressure wound therapy in the diabetic foot: result of the tuscon expert concensus conference (TECC) on V.A.C. Ostomy Wound Manage. 2004;50(4 Suppl B):3s–27s.PubMedGoogle Scholar
  42. 42.
    Banwell PE, Teot L. Topical negative pressure (TNP): the evolution of a novel wound therapy. J Wound Care. 2003;12:22–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Armstrong DG, AJM B, Banwell P. Topical negative pressure: management of complex diabetic foot wounds. Oxford: Oxford Wound Healing Society; 2004.Google Scholar
  44. 44.
    Zgnonis T, Stapleton JJ, Girard-Powell VA, et al. Surgical management of diabetic foot infections and amputations. AORN J. 2008;87(5):935–46.CrossRefGoogle Scholar
  45. 45.
    Morykwas MJ, et al. Stat of basic research and physiologic foundation. Plast Reconstr Surg. 2006;1117(Supplement):121S–126.CrossRefGoogle Scholar
  46. 46.
    Armstrong DG, Attinger CE, Boulton AJ, et al. Guidelines regarding negative wound therapy (NPWT) in the diabetic foot. Ostomy Wound Manage. 2004;50(4B Suppl):3S.PubMedGoogle Scholar
  47. 47.
    Blitz NM. Vacuum assisted closure in lower extremity reconstruction. In: Dockery GL, Craford ME, editors. Lower extremity soft tissue and cutaneous plastic surgery. Edinburgh: Saunders; 2006. p. 343–58.Google Scholar
  48. 48.
    V.A.C. Ultatm Negative pressure wound therapy system. https://www.kci1.Com/KCL1/vac-ulta. Accessed 5 Jan 2013.
  49. 49.
    Kloth LC, Mccullouch JM, Feeder JA. Chapter 12, 13 and 14, wound healing: alternatives in management. Philadelphia: F A Davis company; 1990. p. 221–9.S.Google Scholar
  50. 50.
    Aziz Z, Cullum N, Flemming K. "Electromagnetic therapy for treating venous leg ulcers"(PDF). Cochrane Database Syst Rev. 2015;7:CD002933.  https://doi.org/10.1002/14651858.CD002933.pub6.. PMID 26134172CrossRefGoogle Scholar
  51. 51.
    Aziz Z, Flemming K. Electromagnetic therapy for treating pressure ulcers. Cochrane Database Syst Rev. 2015;9:CD002930.  https://doi.org/10.1002/14651858.CD002930.pub6.. PMID 26334539CrossRefGoogle Scholar
  52. 52.
    Reddy M. Pressure ulcers. BMJ Clin Evid. 2011;2011:3217823.. PMID 21524319Google Scholar
  53. 53.
    Cullum N, Petherick E. Pressure ulcers. BMJ Clin Evid. 2008;2008:2907959.. PMID 19450317Google Scholar
  54. 54.
    Barnes R, Shahin Y, Gohil R, Chetter I. Electrical stimulation vs. standard care for chronic ulcer healing: a systematic review and meta-analysis of randomised controlled trials. Eur J Clin Investig. 2014;44(4):429–40.  https://doi.org/10.1111/eci.12244.. PMID 24456185CrossRefGoogle Scholar
  55. 55.
    Michailidis L, Williams CM, Bergin SM, Haines TP. Comparison of healing rate in diabetes-related foot ulcers with low frequency ultrasonic debridement versus non-surgical sharps debridement: a randomised trial protocol. J Foot Ankle Res. 2014;7(1):1.PubMedPubMedCentralCrossRefGoogle Scholar
  56. 56.
    Kavros SJ, Miller JL, Hanna SW. Treatment of ischemic wounds with noncontact, low-frequency ultrasound: the Mayo Clinic experience, 2004-2006. Adv Skin Wound Care. 2007;20(4):221–2.PubMedCrossRefGoogle Scholar
  57. 57.
    Byl N, McKenzie A, Wong T, West J, Hunt T. Incisional wound healing: a controlled study of low and high dose ultrasound. J Orthop Sports Phys Ther. 1993;18(5):619–28.PubMedCrossRefGoogle Scholar
  58. 58.
    Cameron MH. Chsptor 8 and 12 in physical agents in rehabilitation from research to Practice. 2nd ed. St. Louis Missouri: Saunders; 2003.Google Scholar
  59. 59.
    Ottomann C, Stojadinovic A, Lavin PT, Gannon FH, Heggeness MH, Thiele R, Schaden W, Hartmann B. Ann Surg. 2012;255(1):23–9.PubMedCrossRefGoogle Scholar
  60. 60.
    Mittermayr R, VladoAntonic JH, Kaufmann H, Redl H, Téot L, Stojadinovic A, Schaden W. Ostomy Wound Manage. 2014;60(7):26–39.Google Scholar
  61. 61.
    Qureshi AA, Ross KM, Ogawa R, Orgill DP. Shock wave therapy in wound healing. Plast Reconstr Surg. 2011;128(6):721e–7e.PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Werdin F, Tenenhaus M, Rennekampff HO. Chronic wound care. Lancet. 2008;372(9653):1860–2.PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Wang CJ, Kuo YR, Wu RW, Liu RT, Hsu CS, Wang FS, et al. Extracorporeal shockwave treatment for chronic diabetic foot ulcers. J Surg Res. 2009;152(1):96–103.PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Schaden W, Thiele R, Kölpl C, Pusch M. Shock wave therapy for acute and chronic soft tissue wounds. J Surg Res. 2007;143(1):1–12.PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Wang C-J, Wu R-W, Yang Y-J. Treatment of diabetic foot ulcers: A comparative study of extracorporeal shockwave therapy and hyperbaric oxygen therapy. Diabetes Res Clin Pract. 2011;92(2):187–93.PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Moffatt CJ, O’Hare L. Venous leg ulceration: treatment by high compression bandaging. Ostomy Wound Manage 1995; 41(4):16–8, 20, 22–5.Google Scholar
  67. 67.
    Partsch H. Compression therapy of the legs. A review. J Dermatol Surg Oncol. 1991;17(10):799–805.PubMedCrossRefPubMedCentralGoogle Scholar
  68. 68.
    Kota AA, Selvaraj AD, Premkumar P, Agarwal S. Four Layer Dressing in the management of chronic venous ulcers. Wound Medicine. 2014;5:21–4.CrossRefGoogle Scholar
  69. 69.
    iDATA Research, Inc. U.S. Market for chronic venous insufficiency treatment. 2009.Google Scholar
  70. 70.
    McGuckin M, Waterman R, Brooks J, et al. Validation of leg ulcer guide-lines in the United States and United Kingdom. Am J Surg. 2002;183:132–7.PubMedCrossRefPubMedCentralGoogle Scholar
  71. 71.
    McDaniel HB, Marston WA, Farber MA, Mendes RR, Owens LV, Young ML, et al. Recurrence of chronic venous ulcers on the basis of clinical, etiologic, anatomic, and pahtophysiologic criteria and air plethysmography. J Vasc Surg. 2002;35:723–8.PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    Langer V. Preventing leg ulcer recurrence. Indian Dermatol Online J. 2014;5(4):534–5.PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Partsch H. Understanding the pathophysiological effects of compression. In: Understanding compression therapy. EWMA Position document. London: MEP Ltd; 2003. p. 2–4.Google Scholar
  74. 74.
    Marston W, Vowden K. Compression therapy: a guide to safe practice. In: Understanding compression therapy: EWMA Position document. London: MEP Ltd; 2003. p. 11–7.Google Scholar
  75. 75.
    Cameron MH. Chapter 8 and 12 in Physical agents in rehabilitation from research to Practice. 2nd ed. St. Louis Missouri: Saunders; 2003.Google Scholar
  76. 76.
    Chromey PA. The efficacy of carbon dioxide laser surgery for adjunct ulcer therapy. Clin Podiatr Med Surg. 1992;9:709–19.PubMedGoogle Scholar
  77. 77.
    Sugrue ME, Carolan J, Leen EJ, Feeley TM, Moore DJ, Shanik GD. The use of infrared laser therapy in the treatment of venous ulceration. Ann Vasc Surg. 1990;4:179–81.PubMedCrossRefGoogle Scholar
  78. 78.
    Lundeberg T, Malm M. Low-power HeNe laser treatment of venous leg ulcers. Ann Plast Surg. 1991;27:537–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2020

Authors and Affiliations

  • Vibhakar Vachhrajani
    • 1
  • Payal Khakhkhar
    • 1
  1. 1.Diabetic foot and wound managementVijay Vachhrajani Memorial Hospital RajkotIndia

Personalised recommendations